CIK 0001653087 · Accelerated filer<br>Smaller reporting company
Alector, Inc.
Sign in to watch- Ticker
- ALEC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 822933343
- Phone
- 415-231-5660
- Business address
- 131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Alector LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $296,087
- in 3 filings
Net −$296,087. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 76 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-07-02 | King Robert Chief Development Officer | Option exercise · Employee Stock Option (right to buy) | −30,000 | 120,000 | ||
| 2021-07-02 | King Robert Chief Development Officer | Option exercise · Employee Stock Option (right to buy) | −30,000 | 70,000 | ||
| 2021-07-02 | Paul Robert Chief Medical Officer | Option exercise | +17,326 | $17.15 | $297K | 264,319 |
| 2021-07-02 | Paul Robert Chief Medical Officer | Sale | −30,000 | $31.14 | $934K | 234,319 |
| 2021-07-02 | Paul Robert Chief Medical Officer | Option exercise · Employee Stock Option (right to buy) | −17,326 | 129,549 | ||
| 2021-07-01 | Paul Robert Chief Medical Officer | Sale | −26,726 | $22.23 | $594K | 246,993 |
| 2021-06-17 | Yaffe Kristine Director | Grant or award · Stock Option (right to buy) | +25,709 | 25,709 | ||
| 2021-06-17 | Wehner David M. Director | Grant or award · Stock Option (right to buy) | +25,709 | 25,709 | ||
| 2021-06-17 | SCHELLER RICHARD H Director | Grant or award · Stock Option (right to buy) | +25,709 | 25,709 | ||
| 2021-06-17 | MCGUIRE TERRANCE Director | Grant or award · Stock Option (right to buy) | +25,709 | 25,709 | ||
| 2021-06-17 | LAVIGNE LOUIS J JR Director | Grant or award · Stock Option (right to buy) | +25,709 | 25,709 | ||
| 2021-06-17 | Hammond Paula Director | Grant or award · Stock Option (right to buy) | +25,709 | 25,709 | ||
| 2021-06-17 | Gerngross Tillman U. Director | Grant or award · Stock Option (right to buy) | +25,709 | 25,709 | ||
| 2021-06-16 | Paul Robert Chief Medical Officer | Option exercise | +4,600 | $10.14 | $47K | 278,319 |
| 2021-06-16 | Paul Robert Chief Medical Officer | Sale | −4,600 | $22.18 | $102K | 273,719 |
| 2021-06-16 | Paul Robert Chief Medical Officer | Option exercise · Employee Stock Option (right to buy) | −4,600 | 51,867 | ||
| 2021-06-15 | Paul Robert Chief Medical Officer | Option exercise | +17,100 | $8.16 | $140K | 290,819 |
| 2021-06-15 | Paul Robert Chief Medical Officer | Option exercise | +12,900 | $10.14 | $131K | 303,719 |
| 2021-06-15 | Paul Robert Chief Medical Officer | Sale | −30,000 | $22.07 | $662K | 273,719 |
| 2021-06-15 | Paul Robert Chief Medical Officer | Option exercise · Employee Stock Option (right to buy) | −17,100 | 97,983 |
Page 19 of 23 · 454 trades